Whalegun
Home

Joseph P. Lyssikatos, Chief Scientific Officer: Enliven Therapeutics ELVN Sell · Filed 25/09/23

Trade details

Type
Insider sale
Amount
$93,065.7
Shares · price
4,870 sh · $19.11 a share
Held after
935,318 sh
Stock
Enliven Therapeutics ELVN
Person
Joseph P. LyssikatosChief Scientific Officer
Trade date
25/09/19
Filed
25/09/23
Days to filing
4 days

Sold 0.5% of holdings

Share of holding sold
0.5%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/20~25/10/19

Joseph P. Lyssikatos's recent trades

  • Joseph P. Lyssikatos

    Planned sale10b5-1 planEnliven Therapeutics

    $1.1M

    Filed 04/30

  • Joseph P. Lyssikatos

    Planned sale10b5-1 planEnliven Therapeutics

    $914.8K

    Filed 03/31

  • Joseph P. Lyssikatos

    Planned sale10b5-1 planEnliven Therapeutics

    $2M

    Filed 02/18

  • Joseph P. Lyssikatos

    Sell10b5-1 planEnliven Therapeutics

    $145.2K

    Filed 02/10

  • Joseph P. Lyssikatos

    Sell10b5-1 planEnliven Therapeutics

    $390.3K

    Filed 01/22